カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Peptide Antibiotics Sterile Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19525）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19525
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ペプチド抗生物質無菌注射剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のペプチド抗生物質無菌注射剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ペプチド抗生物質無菌注射剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・リボソーム合成ペプチド、非リボソーム合成ペプチド

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局

世界のペプチド抗生物質無菌注射剤市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Novartis、Eli Lilly、Takeda Pharmaceutical Co. Ltd、GlaxoSmithKline、Abbott Laboratories、Sanofi、Baxter International、AstraZeneca、Merck

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ペプチド抗生物質無菌注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なペプチド抗生物質無菌注射剤メーカーの企業概要、2019年～2022年までのペプチド抗生物質無菌注射剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なペプチド抗生物質無菌注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ペプチド抗生物質無菌注射剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのペプチド抗生物質無菌注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのペプチド抗生物質無菌注射剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびペプチド抗生物質無菌注射剤の産業チェーンを掲載しています。
・第13、14、15章では、ペプチド抗生物質無菌注射剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ペプチド抗生物質無菌注射剤の概要
- 種類別分析（2017年vs2021年vs2028年）：リボソーム合成ペプチド、非リボソーム合成ペプチド
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
- 世界のペプチド抗生物質無菌注射剤市場規模・予測
- 世界のペプチド抗生物質無菌注射剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Novartis、Eli Lilly、Takeda Pharmaceutical Co. Ltd、GlaxoSmithKline、Abbott Laboratories、Sanofi、Baxter International、AstraZeneca、Merck
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：リボソーム合成ペプチド、非リボソーム合成ペプチド
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
・ペプチド抗生物質無菌注射剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ペプチド抗生物質無菌注射剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ペプチド抗生物質無菌注射剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ペプチド抗生物質無菌注射剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ペプチド抗生物質無菌注射剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Peptide Antibiotics Sterile Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peptide Antibiotics Sterile Injectable Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Peptide Antibiotics Sterile Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ribosomal Synthesized Peptides segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Peptide Antibiotics Sterile Injectable Drugs include Pfizer, Novartis, Eli Lilly, Takeda Pharmaceutical Co. Ltd, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peptide Antibiotics Sterile Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ribosomal Synthesized Peptides
Non-ribosomal Synthesized Peptides
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Peptide Antibiotics Sterile Injectable Drugs market are listed below:
Pfizer
Novartis
Eli Lilly
Takeda Pharmaceutical Co. Ltd
GlaxoSmithKline
Abbott Laboratories
Sanofi
Baxter International
AstraZeneca
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide Antibiotics Sterile Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptide Antibiotics Sterile Injectable Drugs, with price, sales, revenue and global market share of Peptide Antibiotics Sterile Injectable Drugs from 2019 to 2022.
Chapter 3, the Peptide Antibiotics Sterile Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide Antibiotics Sterile Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Peptide Antibiotics Sterile Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide Antibiotics Sterile Injectable Drugs.
Chapter 13, 14, and 15, to describe Peptide Antibiotics Sterile Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Peptide Antibiotics Sterile Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ribosomal Synthesized Peptides
1.2.3 Non-ribosomal Synthesized Peptides
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Peptide Antibiotics Sterile Injectable Drugs Market Size & Forecast
1.4.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume (2017-2028)
1.4.3 Global Peptide Antibiotics Sterile Injectable Drugs Price (2017-2028)
1.5 Global Peptide Antibiotics Sterile Injectable Drugs Production Capacity Analysis
1.5.1 Global Peptide Antibiotics Sterile Injectable Drugs Total Production Capacity (2017-2028)
1.5.2 Global Peptide Antibiotics Sterile Injectable Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peptide Antibiotics Sterile Injectable Drugs Market Drivers
1.6.2 Peptide Antibiotics Sterile Injectable Drugs Market Restraints
1.6.3 Peptide Antibiotics Sterile Injectable Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.1.4 Pfizer Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.2.4 Novartis Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.3.4 Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Takeda Pharmaceutical Co. Ltd
2.4.1 Takeda Pharmaceutical Co. Ltd Details
2.4.2 Takeda Pharmaceutical Co. Ltd Major Business
2.4.3 Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.4.4 Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.5.4 GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business
2.6.3 Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.6.4 Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.7.4 Sanofi Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Baxter International
2.8.1 Baxter International Details
2.8.2 Baxter International Major Business
2.8.3 Baxter International Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.8.4 Baxter International Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.9.4 AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Peptide Antibiotics Sterile Injectable Drugs Product and Services
2.10.4 Merck Peptide Antibiotics Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Peptide Antibiotics Sterile Injectable Drugs Breakdown Data by Manufacturer
3.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Peptide Antibiotics Sterile Injectable Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Peptide Antibiotics Sterile Injectable Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Peptide Antibiotics Sterile Injectable Drugs Manufacturer Market Share in 2021
3.5 Global Peptide Antibiotics Sterile Injectable Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Peptide Antibiotics Sterile Injectable Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Region
4.1.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2017-2028)
4.2 North America Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028)
4.3 Europe Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028)
4.4 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028)
4.5 South America Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028)
4.6 Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Type (2017-2028)
5.2 Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Type (2017-2028)
5.3 Global Peptide Antibiotics Sterile Injectable Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Application (2017-2028)
6.2 Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Application (2017-2028)
6.3 Global Peptide Antibiotics Sterile Injectable Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2028)
7.2 North America Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2028)
7.3 North America Peptide Antibiotics Sterile Injectable Drugs Market Size by Country
7.3.1 North America Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2028)
8.2 Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2028)
8.3 Europe Peptide Antibiotics Sterile Injectable Drugs Market Size by Country
8.3.1 Europe Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Market Size by Region
9.3.1 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2028)
10.2 South America Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2028)
10.3 South America Peptide Antibiotics Sterile Injectable Drugs Market Size by Country
10.3.1 South America Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Market Size by Country
11.3.1 Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Peptide Antibiotics Sterile Injectable Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Peptide Antibiotics Sterile Injectable Drugs
12.3 Peptide Antibiotics Sterile Injectable Drugs Production Process
12.4 Peptide Antibiotics Sterile Injectable Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Peptide Antibiotics Sterile Injectable Drugs Typical Distributors
13.3 Peptide Antibiotics Sterile Injectable Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 6. Pfizer Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 10. Novartis Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 14. Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Takeda Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 16. Takeda Pharmaceutical Co. Ltd Major Business
Table 17. Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 18. Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 22. GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Laboratories Major Business
Table 25. Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 26. Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 30. Sanofi Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Baxter International Basic Information, Manufacturing Base and Competitors
Table 32. Baxter International Major Business
Table 33. Baxter International Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 34. Baxter International Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca Major Business
Table 37. AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 38. AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Merck Basic Information, Manufacturing Base and Competitors
Table 40. Merck Major Business
Table 41. Merck Peptide Antibiotics Sterile Injectable Drugs Product and Services
Table 42. Merck Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Peptide Antibiotics Sterile Injectable Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Peptide Antibiotics Sterile Injectable Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Peptide Antibiotics Sterile Injectable Drugs Production Site of Key Manufacturer
Table 48. Peptide Antibiotics Sterile Injectable Drugs New Entrant and Capacity Expansion Plans
Table 49. Peptide Antibiotics Sterile Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Peptide Antibiotics Sterile Injectable Drugs Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Peptide Antibiotics Sterile Injectable Drugs Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Peptide Antibiotics Sterile Injectable Drugs Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Peptide Antibiotics Sterile Injectable Drugs Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Peptide Antibiotics Sterile Injectable Drugs Raw Material
Table 107. Key Manufacturers of Peptide Antibiotics Sterile Injectable Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Peptide Antibiotics Sterile Injectable Drugs Typical Distributors
Table 111. Peptide Antibiotics Sterile Injectable Drugs Typical Customers
List of Figures
Figure 1. Peptide Antibiotics Sterile Injectable Drugs Picture
Figure 2. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Type in 2021
Figure 3. Ribosomal Synthesized Peptides
Figure 4. Non-ribosomal Synthesized Peptides
Figure 5. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Peptide Antibiotics Sterile Injectable Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Peptide Antibiotics Sterile Injectable Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Peptide Antibiotics Sterile Injectable Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Peptide Antibiotics Sterile Injectable Drugs Price (2017-2028) & (US$/Unit)
Figure 13. Global Peptide Antibiotics Sterile Injectable Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Peptide Antibiotics Sterile Injectable Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Peptide Antibiotics Sterile Injectable Drugs Market Drivers
Figure 16. Peptide Antibiotics Sterile Injectable Drugs Market Restraints
Figure 17. Peptide Antibiotics Sterile Injectable Drugs Market Trends
Figure 18. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Peptide Antibiotics Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Peptide Antibiotics Sterile Injectable Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Peptide Antibiotics Sterile Injectable Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Peptide Antibiotics Sterile Injectable Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Peptide Antibiotics Sterile Injectable Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Peptide Antibiotics Sterile Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Peptide Antibiotics Sterile Injectable Drugs in 2021
Figure 77. Manufacturing Process Analysis of Peptide Antibiotics Sterile Injectable Drugs
Figure 78. Peptide Antibiotics Sterile Injectable Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 滅菌注射剤受託製造のグローバル市場展望 2023年-2029年：低分子、高分子
  • 世界の注射用糖尿病治療薬市場2022年：市場規模予測（～2028年）
  • 世界の2型糖尿病用注射剤市場2022年：市場規模予測（～2028年）
  • 世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）
  • 世界の注射用発作治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19525 )"世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）" (英文：Global Peptide Antibiotics Sterile Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。